Literature DB >> 10323475

Blastic mantle cell leukemia: a previously undescribed form.

C H Dunphy1, J C Hancock, J J Rodriguez, J G Hilton.   

Abstract

The leukemic phase of mantle cell lymphoma (mantle cell leukemia) is defined as an absolute lymphocyte count of greater than 4,000/microliter and characterized by the presence of relatively small, slightly irregular lymphocytes in the peripheral blood. Although a variant of mantle cell lymphoma with blastic morphsology exists and has been previously well described, a blastic morphologic variant of mantle cell leukemia has not been described. We report such a case in a 74-year-old male who presented with splenic rupture and an elevated white blood cell (WBC) count. The diagnosis was based on flow cytometric immunophenotyping and the cytomorphology of the peripheral blood.

Entities:  

Mesh:

Year:  1999        PMID: 10323475      PMCID: PMC6807769          DOI: 10.1002/(sici)1098-2825(1999)13:3<112::aid-jcla4>3.0.co;2-j

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  13 in total

1.  Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations.

Authors:  P Lardelli; M A Bookman; J Sundeen; D L Longo; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1990-08       Impact factor: 6.394

2.  Mantle zone lymphoma. A clinicopathologic study of 22 cases.

Authors:  M J Duggan; D D Weisenburger; Y L Ye; M A Bast; J L Pierson; J Linder; J O Armitage
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

3.  Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma.

Authors:  S Kumar; G A Green; J Teruya-Feldstein; M Raffeld; E S Jaffe
Journal:  Mod Pathol       Date:  1996-09       Impact factor: 7.842

Review 4.  Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma.

Authors:  R A Shivdasani; J L Hess; A T Skarin; G S Pinkus
Journal:  J Clin Oncol       Date:  1993-04       Impact factor: 44.544

Review 5.  Immunohistological analysis of human lymphoma: correlation of histological and immunological categories.

Authors:  H Stein; K Lennert; A C Feller; D Y Mason
Journal:  Adv Cancer Res       Date:  1984       Impact factor: 6.242

6.  CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma.

Authors:  C H Dunphy; S E Wheaton; S L Perkins
Journal:  Mod Pathol       Date:  1997-08       Impact factor: 7.842

7.  Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.

Authors:  L R Zukerberg; L J Medeiros; J A Ferry; N L Harris
Journal:  Am J Clin Pathol       Date:  1993-10       Impact factor: 2.493

8.  Malignant lymphoma presenting with prominent splenomegaly. A clinicopathologic study with special reference to intermediate cell lymphoma.

Authors:  S Narang; B C Wolf; R S Neiman
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

9.  Patterns of survival in mantle cell lymphoma.

Authors:  E Zucca; E Roggero; G Pinotti; E Pedrinis; C Cappella; A Venco; F Cavalli
Journal:  Ann Oncol       Date:  1995-03       Impact factor: 32.976

10.  The morphologic spectrum of non-Hodgkin's lymphomas with BCL1/cyclin D1 gene rearrangements.

Authors:  S H Swerdlow; L R Zukerberg; W I Yang; N L Harris; M E Williams
Journal:  Am J Surg Pathol       Date:  1996-05       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.